• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Motus GI touts Pure-Vu clinical data

Motus GI touts Pure-Vu clinical data

November 1, 2016 By Sarah Faulkner

MOTUS touts Pure-Vu clinical dataDespite a 24-hour liquid diet and a purgative to clean the bowels to prepare for a colonoscopy, patients are poorly prepped in 20% of the 15 million colonoscopies performed worldwide each year, according to Motus GI CEO Mark Pomeranz.

This can mean that patients need to return for a 2nd visit and doctors can miss cancerous lesions. Some people refuse to get colonoscopies in the 1st place, because the preparation is so unpleasant, which has major consequences for colorectal cancer screening, Pomeranz told MassDevice.com.

“Of all the major cancers, it has the lowest adherence to screening,” he told us. “You only have just over 60% compliance of folks staying up with their cancer screening. One of the, if not the biggest, deterrent for that is the whole arduous prep regime.”

Tirat Carmel, Israel-based Motus GI says its Pure-Vu cleansing can significantly increase the number patients with adequately cleansed colons for colonoscopy, according to new clinical trial data. The device is integrated directly with a standard colonoscope to preform intra-procedural cleaning of poorly prepared colons.

In a clinical trial, researchers evaluated the Pure-Vu device in 50 colonoscopies, using a regimen of an 18-24 hour liquid diet and bisacodyl tablets designed to deliberately create inadequately prepped colons.

The team found that the Pure-Vu system significantly increased the number of participants with an adequate cleansing level from 31% at baseline to 98% after use of the device.

Inadequately prepped colons put a burden on the healthcare system, as patients are sometimes told that they must return for a 2nd procedure. In-patient procedures are even trickier, Pomeranz said, because often these patients need to spend 2 days in a hospital bed just to get them clean enough for a quality exam.

“You can imagine the cost of that,” Pomeranz told us. “You’re looking at anywhere between $1,800 to $2,000 a day just for the cost of a hospital bed.”

Reimbursement for physicians is also challenged by poor colonoscopy prep, he said. “The reimbursement is only going to get worse if [doctors] don’t have a successful outcome and we actually see more and more things happening where the burden of prep is going to start to move more into the physician side than the patient side.

“Obviously with all that burden, there is certainly significant opportunities with a device that can clean the colon incredibly well to help change that whole structure and paradigm and really revolutionize the whole experience,” Pomeranz said.

The Pure-Vu system won 510(k) clearance from the FDA in September 2016; Pomeranz told us that the company will soon pursue CE Mark approval in the European Union.

Filed Under: Clinical Trials, Endoscopic, Hospital Care Tagged With: MOTUS GI

More recent news

  • Aurora Spine begins first procedures with Aero lumbar fusion system
  • Caranx Medical surgical robot TaviPilot AI software wins FDA clearance
  • InspireMD launches carotid stent in U.S. after FDA approval
  • Neuros Medical raises $56M Series D to support nerve stim tech
  • CorWave reports first-in-human LVAD implant

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy